News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Cavit Sciences, Inc. Announces Status of the Company’s Advancement of Tubercin
August 23, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
DELRAY BEACH, FL--(MARKET WIRE)--Aug 23, 2007 -- Cavit Sciences, Inc. ("Cavit") (OTC BB:CVIT.OB - News) today announced the status of the Company's advancement of Tubercin.
Twitter
LinkedIn
Facebook
Email
Print